TGA Approval

ILARIS canakinumab 150 mg powder for injection vial (159573)

ARTG ID

159573

ARTG Name

ILARIS canakinumab 150 mg powder for injection vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

May 10, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2024-CMI-01656-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-01842-1

Ingredient Name

Canakinumab

Empowering clinical research with data-driven insights and AI-powered tools.

ILARIS canakinumab 150 mg powder for injection vial (159573) - TGA 批准文号 | MedPath